U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06853184) titled 'Study Evaluating the Efficacy and Safety of Artesunate' on Feb. 25.
Brief Summary: This study is a randomized, open-label, active comparator-controlled, dose-ranging trial of the efficacy and safety of IV artesunate in combination with IV GCV or oral VGCV and SOC treatment compared to GCV or VGCV monotherapy and SOC treatment in SOT recipients with clinically significant CMV infection.
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
CMV Infection
Intervention:
DRUG: Artesunate
Low Dose Artesunate: 2.4 mg/kg IV artesunate once daily for 14 days + GCV or VGCV and SOC per local institutional practices High Dose Ar...